meta_pixel
Tapesearch Logo
Log in
STEM-Talk

Episode 74: Robert Whitaker: the drug-based paradigm of psychiatric care in the U.S.

STEM-Talk

Dawn Kernagis and Ken Ford

Health & Fitness, Nutrition, Science, Natural Sciences, Alternative Health

4.6 • 694 Ratings

🗓️ 9 October 2018

⏱️ 75 minutes

🧾️ Download transcript

Summary

Today’s guest is a science journalist and author who has written extensively about the pharmaceutical industry. Robert Whitaker is also the founder of Mad in America, a nonprofit organization that focuses on getting people to rethink psychiatric care in the United States. As you will learn in today’s episode, one in six Americans takes a psychiatric drug. More than 130,000 children under the age of five are taking addictive anti-anxiety drugs prescribed by doctors. Whitaker has spent most of his career focused on changing the current drug-based paradigm of psychiatric care in the U.S. He has written three books about the pharmaceutical industry and the psychiatric profession. He has looked at how drugs used for depression, bipolar disorder and schizophrenia are causing a spike in America’s disability numbers. He also has investigated the history of medications prescribed for these disorders, how they are marketed, and why they’ve grown in popularity. Discover magazine named Whitaker’s first book, “Mad in America,” one of the best science books of 2002. His second book, “Anatomy of an Epidemic,” won the 2010 Investigative Reporters and Editors book award for best investigative journalism. His third book, “Psychiatry Under the Influence,” is a textbook used in university classrooms around the country. In today’s interview, we discuss: [00:11:08] When Robert first became disillusioned with the pharmaceutical industry [00:16:53] How Robert’s investigation into schizophrenia in the U.S. led him to write his first book,  “Mad In America.” [00:26:58] Why the U.S. has seen such a sharp increase in the number of disabled, mentally ill people since the advent of psychotropic medications. [00:45:10] How many drugs may have efficacy in clinical trials over the short term, but overwhelming evidence shows over the long term many medications actually increase a person’s risk of becoming chronically ill and functionally impaired. [01:00:43] Robert’s investigation into the FDA’s review of studies that looked at Prozac [01:03:38] Antidepressants and their side effects. [01:08:40] How concerns over ADHD have led to an alarming percentage of children, especially boys, being drugged for exhibiting what once considered normal or at least acceptable behavior. And much more. Show notes:  [00:02:24] Robert talks about growing up in Denver and taking family vacations around the country. [00:03:48] Robert explains how in high school he was so convinced he was going to attend Stanford University that he didn’t bother to apply to another college. [00:05:48] Dawn mentions that Robert graduated with a degree in English literature and after college decided he wanted to lead a life of adventure. Dawn asks him where that career path took him. [00:07:11] Robert talks about abandoning his dream of becoming a novelist and taking a job at a small newspaper in upstate New York. [00:08:51] Dawn points out that Robert eventually went to work for a newspaper in Albany, N.Y., where he became a medical writer. She asks him about the year he spent as a Knight Science Journalism fellow at MIT. [00:09:50] Ken asks Robert about moving to Boston and becoming director of publications at Harvard Medical School. [00:11:08] Robert talks about co-founding CenterWatch, a publishing company focused on the business of clinical drug trials. He describes how he became disillusioned with the pharmaceutical industry because it seemed to him that clinical trials had become so commercialized that they were corrupting the testing of new drugs. [00:13:44] Ken mentions that during this period, Robert came upon information about abuses of psychiatric patients in research settings. Ken asks Robert to share how he took this information and went to the Boston Globe to propose a newspaper series. [00:16:53] Dawn describes how the work Robert did for this series in the Boston Globe led him to information that schizophrenics in ...

Transcript

Click on a timestamp to play from that location

0:00.0

Welcome to STEM Talk.

0:01.2

Stem Talk.

0:01.8

Stem Talk.

0:03.3

Stem Talk.

0:03.7

Stem Talk, where we introduce you to fascinating people who passionately inhabit the scientific and technical frontiers of our society.

0:14.0

Hi, I'm your host, Don Cornagus, and joining me to introduce today's podcast as a man behind the curtain, Dr. Ken Ford, IHMC's director and chairman of the

0:21.8

double secret selection committee that selects all the guests who appear on STEM Talk.

0:25.1

Hi, Dawn, great to be here today. Today's guest is Robert Whitaker, a science journalist and author,

0:32.5

who has written extensively about psychiatry and the pharmaceutical industry. He has written

0:37.2

three books that show how drugs

0:39.4

used for depression, ADHD, bipolar disorder, and schizophrenia can be related to a spike in

0:47.5

America's disability numbers. His investigations have traced the history of the medications that are

0:52.7

prescribed for these disorders, how they are marketed, and how they've grown in popularity. He's traced the history of the medications that are prescribed for these disorders,

0:54.3

how they are marketed, and how they've grown in popularity.

0:57.0

And he's also the founder of Mad in America.com, a website focused on encouraging people

1:01.7

to rethink psychiatric care in the United States.

1:04.4

But before we get to today's interview with Robert, we have some housekeeping to take care

1:07.8

of.

1:08.8

First, we really appreciate all of you who subscribe to STEM Talk,

1:11.2

and we are especially appreciative of all the wonderful five-star reviews that have been piling up.

1:14.7

As we announced in several earlier episodes, the Double Secret Selection Committee has been

1:18.4

continually and carefully reviewing iTunes, Google, Stitcher, and other podcast apps for the wittiest

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Dawn Kernagis and Ken Ford, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Dawn Kernagis and Ken Ford and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2025.